Urbas Grupo Financiero Statistics

Total Valuation

BME:UBS has a market cap or net worth of EUR 102.79 million. The enterprise value is 220.79 million.

Market Cap	102.79M
Enterprise Value	220.79M

Important Dates

The next estimated earnings date is Thursday, June 26, 2025.

Earnings Date	Jun 26, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:UBS has 46.72 billion shares outstanding. The number of shares has increased by 1.60% in one year.

Current Share Class	n/a
Shares Outstanding	46.72B
Shares Change (YoY)	+1.60%
Shares Change (QoQ)	-0.22%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	0.04%
Float	27.09B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.60
PB Ratio	0.20
P/TBV Ratio	0.29
P/FCF Ratio	15.96
P/OCF Ratio	15.78
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.62
EV / Sales	1.29
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	34.28

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.27.

Current Ratio	2.05
Quick Ratio	0.46
Debt / Equity	0.27
Debt / EBITDA	273.29
Debt / FCF	21.22
Interest Coverage	-0.27

Financial Efficiency

Return on equity (ROE) is -24.12% and return on invested capital (ROIC) is -0.51%.

Return on Equity (ROE)	-24.12%
Return on Assets (ROA)	-0.37%
Return on Invested Capital (ROIC)	-0.51%
Return on Capital Employed (ROCE)	-0.97%
Revenue Per Employee	253,086
Profits Per Employee	-202,180
Employee Count	676
Asset Turnover	0.16
Inventory Turnover	0.20

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.22% in the last 52 weeks. The beta is -0.53, so BME:UBS's price volatility has been lower than the market average.

Beta (5Y)	-0.53
52-Week Price Change	-51.22%
50-Day Moving Average	0.00
200-Day Moving Average	0.00
Relative Strength Index (RSI)	36.40
Average Volume (20 Days)	106,058,374

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:UBS had revenue of EUR 171.09 million and -136.67 million in losses. Loss per share was -0.00.

Revenue	171.09M
Gross Profit	60.97M
Operating Income	-6.18M
Pretax Income	-141.62M
Net Income	-136.67M
EBITDA	500,000
EBIT	-6.18M
Loss Per Share	-0.00

Full Income Statement

Balance Sheet

The company has 30.39 million in cash and 136.64 million in debt, giving a net cash position of -106.26 million or -0.00 per share.

Cash & Cash Equivalents	30.39M
Total Debt	136.64M
Net Cash	-106.26M
Net Cash Per Share	-0.00
Equity (Book Value)	515.53M
Book Value Per Share	0.01
Working Capital	311.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 6.51 million and capital expenditures -72,000, giving a free cash flow of 6.44 million.

Operating Cash Flow	6.51M
Capital Expenditures	-72,000
Free Cash Flow	6.44M
FCF Per Share	0.00

Full Cash Flow Statement

Margins

Gross margin is 35.64%, with operating and profit margins of -3.61% and -79.89%.

Gross Margin	35.64%
Operating Margin	-3.61%
Pretax Margin	-82.78%
Profit Margin	-79.89%
EBITDA Margin	0.29%
EBIT Margin	-3.61%
FCF Margin	3.76%

Dividends & Yields

BME:UBS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.60%
Shareholder Yield	-1.60%
Earnings Yield	-132.97%
FCF Yield	6.27%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:UBS has an Altman Z-Score of 0.6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.6
Piotroski F-Score	n/a